Individual Study / LSPIPSA-HCW

Longitudinal study on prevalence, incidence and persistence of SARS-CoV-2 antibodies in health care workers using home blood collection kits and a fully automated ELISA and ECLIA antibody assay

Longitudinal study on prevalence, incidence and persistence of SARS-CoV-2 antibodies in health care workers using home blood collection kits and a fully automated ELISA and ECLIA antibody assay

Networks -
Datasets -
Variables -
Start Year
2020
End Year
2022

Members

Download
Investigators Contacts
  • Dr. Keith Jarvi
    Mount Sinai Hospital
  • Susan Lau
    Mount Sinai Hospital

Design

Study design
Cohort
Follow Up
For the longitudinal participants, follow-up questionnaires were completed at 3, 6, 12 and 18 months following the initial assays; and 30 days after the completion of the vaccination. An identical process was followed for the serological testing 3, 6, 12 and 18 months following the initial assays; and 30 days after the completion of vaccination.

Recruitment

Recruitment Target
  • Individuals

Number of Participants

Number of Participants
1,720
Number of Participants with Biological Samples
1,720
Supplementary Information
COVID-19 infected: 10 participants
COVID-19 negative and untested: 10 participants
Mount Sinai Hospital: 1200 Participants
Health Science North (Sudbury): 250 Participants
Sault Area Hospital (Sault Ste Marie): 250 Participants

Access

Availability of data and biosamples

Possible Access to Data
Possible Access to Biosamples
Other

Timeline

Populations

Selection Criteria
Newborns
Twins
Countries
  • Canada
Territory
Toronto
Ethnic Origin
Health Status
  • COVID-19 positive and recovered

Recruitment

Sources of recruitment
  • Specific population
Specific Population
  • Clinic patients
Supplementary Information
COVID-19 positive and recovered patients are recruited from Mount Sinai Hospital patient population. Patients are approached to participate, then they are provided with the consent form and information on how to contact the research coordinator for this study. The COVID-19 infected patients participate in this study after they have recovered from the infection and are no longer infected (not hospitalized patients).

Number of Participants

Number of Participants
10
Number of Participants with Biological Samples
10
Data Collection Event
Start Date
2020-09
Data sources
  • Biosamples
Data sources - Biosamples
  • Blood
Selection Criteria
Newborns
Twins
Countries
  • Canada
Territory
Toronto
Ethnic Origin
Health Status
  • COVID-19 untested or previously negative

Recruitment

Sources of recruitment
  • Specific population
Specific Population
  • Members of an association
Supplementary Information
Participants will be recruited by word of mouth from within the health care workers at the Mount Sinai Hospital.

Number of Participants

Number of Participants
10
Number of Participants with Biological Samples
10
Data Collection Event
Start Date
2020-09
Data sources
  • Biosamples
Data sources - Biosamples
  • Blood
Selection Criteria
Newborns
Twins
Countries
  • Canada
Territory
Ethnic Origin
Health Status
Other Criteria
Exclusion: Present symptoms compatible with COVID-19 infections and for those with confirmed COVID-19 positive had a negative NP swab test for COVID-19 (recovered from COVID-19)

Recruitment

Sources of recruitment
  • Specific population
Specific Population
  • Members of an association
Supplementary Information
Information about this study was electronically distributed to the health care workers (HCWs) at the Mount Sinai Hospital, Sault Area Hospital and Health Sciences North (Sudbury). Volunteers will contact the research coordinator and will be eligible to participate in the study if they are able to provide the blood samples and if they are willing to complete the entire 18 months of the study.

Number of Participants

Number of Participants
1,700
Number of Participants with Biological Samples
1,700
Data Collection Events
# Name Description Start End
0 LSPIPSA-HCW - Longitudinal - Blood collection Information was collected about type of work, age, sex, race/ethnicity, simple demographic and pre-existing medical issues on the risks of infection with COVID-19 and the severity of the infection ... 2020-09
1 LSPIPSA-HCW - Longitudinal - 3 months follow-up Information was collected about COVID-19 diagnosis and history of symptoms compatible with an infection with COVID-19. Serology testing was done. 2020-12
2 LSPIPSA-HCW - Longitudinal - 6 months follow-up Information was collected about COVID-19 diagnosis and history of symptoms compatible with an infection with COVID-19. Serology testing was done. 2021-03
3 LSPIPSA-HCW - Longitudinal - 12 months follow-up Information was collected about COVID-19 diagnosis and history of symptoms compatible with an infection with COVID-19. Serology testing was done. 2021-09
4 LSPIPSA-HCW - Longitudinal - 18 months follow-up Information was collected about COVID-19 diagnosis and history of symptoms compatible with an infection with COVID-19. Serology testing was done. 2022-03 2022
5 LSPIPSA-HCW - Longitudinal - 1 month post-vaccination Information was collected about COVID-19 diagnosis and history of symptoms compatible with an infection with COVID-19. Serology testing was done. 2021-02 2021

Classifications

Socio-demographic and economic characteristics
Lifestyle and behaviours
Birth, pregnancy and reproductive health history
Perception of health, quality of life, development and functional limitations
Diseases
Symptoms and signs
Medication and supplements
Non-pharmacological interventions
Health and community care services utilization
Death
Physical measures and assessments
Laboratory measures
Cognition, personality and psychological measures and assessments
Life events, life plans, beliefs and values
Preschool, school and work life
Social environment and relationships
Physical environment
Administrative information

Socio-demographic and economic characteristics

Age/birthdate
Sex/gender
Residence
Ethnicity, race and religion
Labour force and retirement

Lifestyle and behaviours

Tobacco

Diseases

Certain infectious and parasitic diseases (A00-B99)
Neoplasms (C00-D48)
Diseases without precise specification or falling into multiple categories

Medication and supplements

Medication and supplement intake

Non-pharmacological interventions

Laboratory diagnosis interventions
Other and unspecified non-pharmacological interventions

Physical measures and assessments

Anthropometry

Laboratory measures

Virology

Preschool, school and work life

Work life

Social environment and relationships

Social participation

Administrative information

Identifiers
Date and time-related information